The Governors of the University of Calgary
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 1966-04-29
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.ucalgary.ca
A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in Canada
Completed
- Conditions
- Non-Alcoholic Fatty Liver DiseaseHepatitis BVaccine Reaction
- First Posted Date
- 2016-12-07
- Last Posted Date
- 2021-11-03
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 82
- Registration Number
- NCT02985450
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
Tolvaptan for Advanced or Refractory Heart Failure
Phase 4
Terminated
- Conditions
- Heart FailureHyponatremia
- Interventions
- Drug: Standard of care diuretic therapyDrug: Tolvaptan
- First Posted Date
- 2016-11-09
- Last Posted Date
- 2020-07-27
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 9
- Registration Number
- NCT02959411
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
The Impact of Disclosing Personalized Depression Risk Information on High-risk Individuals' Outcomes
Not Applicable
Completed
- Conditions
- Depression
- Interventions
- Other: personalized depression risk information
- First Posted Date
- 2016-10-25
- Last Posted Date
- 2021-05-05
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 712
- Registration Number
- NCT02943876
- Locations
- 🇨🇦
Mathison Centre for Mental Health Research and Education, Calgary, Alberta, Canada
🇨🇦JianLi Wang, Calgary, Alberta, Canada
A Comparison of Protein Intake Between ERAS and Conventional Care After Elective Colorectal Surgery
Completed
- Conditions
- Colorectal DisordersSurgery
- Interventions
- Other: ERAS
- First Posted Date
- 2016-10-21
- Last Posted Date
- 2017-05-03
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 115
- Registration Number
- NCT02940665
Umbilical Venous Catheter Insertion Depth in Neonates
Not Applicable
Completed
- Conditions
- Central Venous Catheterization
- Interventions
- Device: UVCDevice: Ultrasound
- First Posted Date
- 2016-10-20
- Last Posted Date
- 2018-05-02
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 200
- Registration Number
- NCT02939690
- Locations
- 🇨🇦
Foothills Medical Center, Calgary, Alberta, Canada
Mgt of Chronic Subdural Hematoma Using Dexamethasone
Phase 2
- Conditions
- Chronic Subdural Hematoma
- Interventions
- Procedure: Any surgical intervention aim at treating chronic subdural hematomaDrug: Dexamethasone
- First Posted Date
- 2016-10-19
- Last Posted Date
- 2020-07-01
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 326
- Registration Number
- NCT02938468
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
Hepatitis A Vaccine Dosing Regimens Among Pediatric Patients on Immunosuppressive Therapy
Not Applicable
Completed
- Conditions
- Autoimmune Rheumatologic Disease
- Interventions
- Biological: Avaxim Pediatric®Biological: Avaxim ® (adult)
- First Posted Date
- 2016-09-28
- Last Posted Date
- 2024-10-03
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 19
- Registration Number
- NCT02917577
- Locations
- 🇨🇦
Alberta Children's Hospital/University of Calgary, Calgary, Alberta, Canada
Hydroxychloroquine in Primary Progressive Multiple Sclerosis
Phase 2
Completed
- Conditions
- Multiple Sclerosis, Primary Progressive
- Interventions
- First Posted Date
- 2016-09-23
- Last Posted Date
- 2021-07-30
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 35
- Registration Number
- NCT02913157
- Locations
- 🇨🇦
MS Clinic Foothills Medical Centre, Calgary, Alberta, Canada
One-year Patient Reported Outcomes Following Hospitalization for Trauma
Terminated
- Conditions
- Wounds and Injuries
- First Posted Date
- 2016-09-21
- Last Posted Date
- 2017-12-07
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 42
- Registration Number
- NCT02909231
- Locations
- 🇨🇦
Foothills Medical Centre, Calgary, Alberta, Canada
🇨🇦Vancouver General Hospital, Vancouver, British Columbia, Canada
Evaluating the Efficacy of Intranasal Oxytocin Among Individuals With Persistent Pain
Phase 2
Completed
- Conditions
- Pelvic PainChronic Pain
- Interventions
- Drug: PlaceboDrug: Intranasal Oxytocin
- First Posted Date
- 2016-09-05
- Last Posted Date
- 2022-05-18
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 24
- Registration Number
- NCT02888574
- Locations
- 🇨🇦
Behavioural Medicine Laboratory, Calgary, Alberta, Canada
© Copyright 2025. All Rights Reserved by MedPath